Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 652 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded May 29 to Jun 2, 2026 · Filed Jun 2, 2026

From May 29 to Jun 2, 2026, Pham Quang X (Director, CEO and Chairman, 10% owner) sold 652 Cadrenal Therapeutics, Inc. shares at an average US$4.72 for US$3,075 under a trading plan, leaving 181,509 shares. Filed Jun 2, 2026 (Form 4).

Sold
652 shares
Price
US$4.72 average (US$4.46 to US$5.01)
Value
US$3,075
Holding after
181,509 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO and Chairman, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 29, 2026Common StockSale303US$5.01181,858Direct
Jun 2, 2026Common StockSale349US$4.46181,509Direct

Source

View original at SEC

Related